NCT05797922

To Evaluate the Effect of Food on the Safety and PK Characteristics of DWP16001 in Healthy Adult Volunteers

A Phase 1 Clinical Trial to Evaluate the Effect of Food on the Pharmacokinetics and Safety of DWP16001 After Administration in Healthy Adult Volunteers

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 32 (estimated)
• Sponsor: Daewoong Pharmaceutical Co. LTD. · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Accepted

Summary

This study aims to evaluate the effect of food on the pharmacokinetics and safety of DWP16001 after oral administration.

Detailed description

The study design is A randomized, Open-label, Oral, Single-dose, Two-way crossover study.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	DWP16001	DWP16001 0.3mg

Timeline

• Start date: 2023-03-09
• Primary completion: 2023-05-31
• Completion: 2023-11-30
• First posted: 2023-04-04
• Last updated: 2023-04-04

Locations

1 site across 1 country: South Korea